Dolasetron Mesylate(CAS: 115956-13-3)

Dolasetron Mesylate (CAS: 115956-13-3) is a white to off-white crystalline powder with a molecular weight of approximately 433.46 g/mol. It is slightly soluble in water and ethanol. Dolasetron Mesylate is moderately reactive towards bases and can undergo hydrolysis. The compound exhibits good solubility in organic solvents such as methanol and acetone. It is commonly used as a prodrug for dolasetron and is known for its antiemetic properties.

Dolasetron Mesylate (CAS: 115956-13-3) is typically synthesized by the methylation of dolasetron hydrochloride. The process involves the reaction of dolasetron hydrochloride with methylsulfonyl chloride in the presence of a base, such as triethylamine, followed by the addition of methylsulfonic acid. The resulting product is dolasetron mesylate, which is then purified through recrystallization from an appropriate solvent.

Dolasetron Mesylate (CAS: 115956-13-3) is primarily used in the pharmaceutical industry. It is an antiemetic drug used to prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. While it has applications in the pharmaceutical field, it is not commonly used in other industries such as polymers, sensors, or semiconductors.

When handling Dolasetron Mesylate (CAS: 115956-13-3), appropriate personal protective equipment (PPE) should be worn, including gloves, lab coat, and safety goggles. It should be stored in a tightly closed container in a cool, dry place away from heat and direct sunlight. Spills should be cleaned up using appropriate absorbent materials and the area should be thoroughly washed. It is advised to refer to the safety data sheet (SDS) for detailed handling and disposal instructions to ensure safety and comply with regulations.